167 related articles for article (PubMed ID: 19496068)
1. Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs.
Sánchez C; Mendoza P; Contreras HR; Vergara J; McCubrey JA; Huidobro C; Castellón EA
Prostate; 2009 Sep; 69(13):1448-59. PubMed ID: 19496068
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins.
Sánchez C; Mercado A; Contreras HR; Mendoza P; Cabezas J; Acevedo C; Huidobro C; Castellón EA
Prostate; 2011 Dec; 71(16):1810-7. PubMed ID: 21480311
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
4. Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines.
Bottke D; Koychev D; Busse A; Heufelder K; Wiegel T; Thiel E; Hinkelbein W; Keilholz U
Radiat Res; 2008 Jul; 170(1):41-8. PubMed ID: 18582150
[TBL] [Abstract][Full Text] [Related]
5. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance in prostate cancer.
van Brussel JP; Mickisch GH
Onkologie; 2003 Apr; 26(2):175-81. PubMed ID: 12771527
[TBL] [Abstract][Full Text] [Related]
7. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Shi LX; Ma R; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Li XL; Zhang HL; Yao Z
Cancer Lett; 2008 Sep; 269(1):101-10. PubMed ID: 18538471
[TBL] [Abstract][Full Text] [Related]
8. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
[TBL] [Abstract][Full Text] [Related]
9. [Induction of multidrug resistance in Tca8113 cells by transient exposure to different chemotherapeutic drugs].
Zhang P; Wang D; Zheng G
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):70-3. PubMed ID: 12674630
[TBL] [Abstract][Full Text] [Related]
10. Role of chemotherapy resistance genes in outcome of neuroblastoma.
de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
[TBL] [Abstract][Full Text] [Related]
11. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
12. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
13. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
14. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity.
Saupe M; Rauschenberger L; Preuß M; Oswald S; Fussek S; Zimmermann U; Walther R; Knabbe C; Burchardt M; Stope MB
World J Urol; 2015 Oct; 33(10):1481-6. PubMed ID: 25544376
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance protein expression of adult T-cell leukemia/lymphoma.
Yasunami T; Wang YH; Tsuji K; Takanashi M; Yamada Y; Motoji T
Leuk Res; 2007 Apr; 31(4):465-70. PubMed ID: 17134750
[TBL] [Abstract][Full Text] [Related]
17. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
18. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
[TBL] [Abstract][Full Text] [Related]
19. Reversal of cisplatin resistance in non-small cell lung cancer stem cells by Taxus chinensis var.
Jiang YQ; Xu XP; Guo QM; Xu XC; Liu QY; An SH; Xu JL; Su F; Tai JB
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706681
[TBL] [Abstract][Full Text] [Related]
20. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
Zhang B; Liu M; Tang HK; Ma HB; Wang C; Chen X; Huang HZ
J Oral Pathol Med; 2012 Feb; 41(2):141-8. PubMed ID: 21793937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
